Home/Pipeline/Alzheimer’s Clinical Trials

Alzheimer’s Clinical Trials

Alzheimer’s Disease

Not Specified (Typically Phase 2-3)Active

Key Facts

Indication

Alzheimer’s Disease

Phase

Not Specified (Typically Phase 2-3)

Status

Active

Company

Boston Clinical Trials

About Boston Clinical Trials

Boston Clinical Trials is a private, revenue-generating clinical research organization (CRO) and site management organization (SMO) based in Roslindale, Massachusetts. Founded in 2008, it has conducted over 300 studies across more than 10 therapeutic areas, primarily focusing on central nervous system disorders, migraines, and other medical specialties. The company's business model is service-based, generating revenue from pharmaceutical and biotech sponsors for patient recruitment, trial execution, and site management. It differentiates itself through patient-centric services like compensation, evening appointments, and a convenient location.

View full company profile

Therapeutic Areas

Neurology Psychiatry Dermatology Gastroenterology Internal Medicine Sexual Dysfunction Urology Migraine

Other Alzheimer’s Disease Drugs

Drug	Company	Phase	Status
RASTRUM™ 3D Alzheimer’s Disease Model	Inventia Life Science	Pre‑clinical	Active
SPC-14	Silo Pharma	Preclinical	Research
Masitinib	AB Science	Phase 3	Active
Vaxine Alzheimer’s Disease Vaccine	Vaxine	Preclinical	Active
Leronlimab	CytoDyn	Phase 1	Phase in progress
Sovateltide	Pharmazz	Preclinical	Active
Alzheimer's Drug	Dawah Pharmaceuticals	Development	Active
ONO-2020	Deciphera Pharmaceuticals	Phase 2	Active
Blarcamesine (ANAVEX®2-73)	Anavex Life Sciences	Phase 2b/3	Ongoing